Reflection Asset Management’s Novavax NVAX Stock Holding History

Reflection Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25	Closed	-$183	–	355
2025 Q4	$183	Buy	+25	New	+$188	﹤0.01%	499

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Reflection Asset Management's NVAX Position: Q1 2026 in Review

Reflection Asset Management sold out of Novavax (NVAX) in Q1 2026, closing a stake of 25 shares — an estimated $183 sold.

Reflection Asset Management first reported a position in NVAX in Q4 2025 and held it in 1 quarter. The position peaked at $183 in Q4 2025. 259 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

Reflection Asset Management reported no remaining Novavax position as of Q1 2026 after selling out during the quarter.
Reflection Asset Management sold 25 Novavax shares in Q1 2026, an estimated $183.
Reflection Asset Management first reported a position in Novavax in Q4 2025 and held it in 1 quarter.
Reflection Asset Management's Novavax position peaked at $183 in Q4 2025.
259 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Reflection Asset Management's 13F filing for Q1 2026, filed 26 Aug 2026.